{
  "resourceType": "DetectedIssue",
  "id": "ddi",
  "text": {
    "status": "generated",
    "div": "\u003cdiv xmlns\u003d\"http://www.w3.org/1999/xhtml\"\u003e\n      \u003cp\u003e\u003cb\u003eSeverity: High\u003c/b\u003e - Risk of internal bleeding\u003c/p\u003e\n      \u003cp\u003eThose who take acetaminophen along with the widely used blood-thinning drug warfarin may face the risk of serious internal bleeding. People on warfarin who take acetaminophen for at least seven days in a row should be closely watched for bleeding.\u003c/p\u003e\n      \u003cul\u003e\n        \u003cli\u003e\u003ca href\u003d\"MedicationStatement/tylenol\"\u003e500 mg Acetaminophen tablet 1/day, PRN since 2010\u003c/a\u003e\u003c/li\u003e\n        \u003cli\u003e\u003ca href\u003d\"MedicationRequest/warfarin\"\u003eWarfarin 1 MG TAB prescribed Jan. 5, 2014\u003c/a\u003e\u003c/li\u003e\n      \u003c/ul\u003e\n      \u003cp\u003eMitigation: Jan 5, 2014 by Dr. Adam Careful: \u003c/p\u003e\n      \u003cp\u003eAsked patient to discontinue regular use of Tylenol and to consult with clinician if they need to resume to allow appropriate INR monitoring\u003c/p\u003e\n    \u003c/div\u003e"
  },
  "status": "final",
  "code": {
    "coding": [
      {
        "system": "http://terminology.hl7.org/CodeSystem/v3-ActCode",
        "code": "DRG",
        "display": "Drug Interaction Alert"
      }
    ]
  },
  "severity": "high",
  "identifiedDateTime": "2014-01-05",
  "author": {
    "reference": "Device/software"
  },
  "implicated": [
    {
      "reference": "MedicationStatement/example001",
      "display": "500 mg Acetaminophen tablet 1/day, PRN since 2010"
    },
    {
      "reference": "MedicationRequest/medrx0331",
      "display": "Warfarin 1 MG TAB prescribed Jan. 15, 2015"
    }
  ],
  "detail": "Risk of internal bleeding.  Those who take acetaminophen along with the widely used blood-thinning drug warfarin may face the risk of serious internal bleeding. People on warfarin who take acetaminophen for at least seven days in a row should be closely watched for bleeding.",
  "mitigation": [
    {
      "action": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/v3-ActCode",
            "code": "13",
            "display": "Stopped Concurrent Therapy"
          }
        ],
        "text": "Asked patient to discontinue regular use of Tylenol and to consult with clinician if they need to resume to allow appropriate INR monitoring"
      },
      "date": "2014-01-05",
      "author": {
        "reference": "Practitioner/example",
        "display": "Dr. Adam Careful"
      }
    }
  ],
  "meta": {
    "tag": [
      {
        "system": "http://terminology.hl7.org/CodeSystem/v3-ActReason",
        "code": "HTEST",
        "display": "test health data"
      }
    ]
  }
}